Form 8-K - Current report:
SEC Accession No. 0001437749-26-017872
Filing Date
2026-05-20
Accepted
2026-05-20 08:38:54
Documents
13
Period of Report
2026-05-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20260519_8k.htm   iXBRL 8-K 26473
2 EXHIBIT 99.1 ex_965638.htm EX-99.1 24255
  Complete submission text file 0001437749-26-017872.txt   190280

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sdev-20260520.xsd EX-101.SCH 3580
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sdev-20260520_def.xml EX-101.DEF 11808
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sdev-20260520_lab.xml EX-101.LAB 15859
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sdev-20260520_pre.xml EX-101.PRE 12023
16 EXTRACTED XBRL INSTANCE DOCUMENT nby20260519_8k_htm.xml XML 2958
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
Stablecoin Development Corp (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 261001601
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)